Probably a done deal Deal is likely going to happen.......
Takeda tried earlier this year to buy Salix as part of a joint bid with private equity firm TPG but the approach, which came a few weeks before Mr. Papa took over as chief executive, was rejected by the board. They wanted to give Papa time to map out a course for the company.
Takeda said in September that it was scouting for multibillion-dollar acquisitions in the United States and other overseas markets as it seeks to boost its core therapy areas, including gastrointestinal medicine.